Complete Microbiome Mapping (NutriPATH)

101 biomarkers Sample: Stool Peer-reviewed

Biomarkers in this category

101 biomarkers · optimal ranges shown

Bifidobacterium longum is a specific species of microscopic non-pathogenic bacteria found naturally in the gastrointestinal tracts of humans as well as in most other animals. It is added to a variety of foods or dietary supplements as a probiotic due to its many health benefits. It is a gram-positive, branched rod-shaped bacterium that produces lactic acid from the fermentation of sugar in the gastrointestinal tract.

Butyrate is a short-chain fatty acid (SCFA) produced in the colon by the bacterial fermentation of undigested carbohydrates, primarily dietary fiber. It serves as a primary energy source for colonocytes (cells of the colon) and has several important roles in maintaining gut health and overall well-being. Beneficial Effects: At appropriate levels, butyrate has several positive effects: → Gut Barrier Integrity: It helps maintain the integrity of the gut barrier, reducing the risk of "leaky gut" and associated inflammatory conditions. → Anti-inflammatory: Butyrate possesses anti-inflammatory properties that can help mitigate inflammation in the gut. → Cancer Prevention: It has been studied for its potential role in reducing the risk of colorectal cancer. → Metabolic Health: Butyrate can improve insulin sensitivity and has other metabolic benefits.

Escherichia species, prominently Escherichia coli (E. coli), are a significant aspect of gastrointestinal (GI) test results due to their diverse roles within the human gut and potential implications for health. E. coli is a common and typically harmless resident of the human intestinal tract, playing a crucial role in maintaining the gut's microbial balance. However, certain strains of E. coli can be pathogenic, leading to various gastrointestinal and extraintestinal diseases. When a GI test indicates elevated or abnormal levels of E. coli, it may signal an infection or a disruption in the gut microbiome's equilibrium. The pathogenic strains of E. coli, such as Enterohemorrhagic E. coli (EHEC), Enterotoxigenic E. coli (ETEC), and others, are particularly noteworthy. These strains can cause symptoms ranging from mild diarrhea to severe abdominal cramps, bloody stools, and even life-threatening conditions like hemolytic uremic syndrome (HUS). The presence of such pathogenic strains is often linked to contaminated food or water and can lead to outbreaks of foodborne illness. Additionally, certain non-pathogenic strains of E. coli can become opportunistic pathogens, especially in individuals with compromised immune systems, leading to infections outside the GI tract, such as urinary tract infections and sepsis. In a GI test, the detection of E. coli is not inherently alarming as it is a standard component of the gut flora. However, the context, such as the strain of E. coli and the patient's symptoms and medical history, is crucial for interpretation. For instance, the presence of toxin-producing E. coli strains would be a significant concern, necessitating further investigation and possibly targeted treatment. Treatment for E. coli infections varies based on the strain and severity of the infection. While some cases may resolve without intervention, others require hydration, electrolyte management, and in some cases, antibiotics. It's important to note that the use of antibiotics in E. coli infections is carefully considered, as certain strains may be resistant, and inappropriate antibiotic use can exacerbate the condition. Overall, Escherichia species in a GI test represent a complex interplay between normal gut colonization and potential pathogenicity, requiring careful clinical assessment to determine their significance in each individual case.

Mucous production may indicate the presence of an infection and/or inflammation.